Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Subcutaneous injection of immune proteins is well tolerated and safe, and is clinically suitable for all patients. Subcutaneous immunoglobulin is superior to intravenous immunoglobulin because it does not require intravenous access and reduces the need for prodrug therapy with glucocorticoids and antihistamines. Due to the reduction of global market participants and the time interval between plasma collection and product launch, the production of subcutaneous immunoglobulin becomes cumbersome and time-consuming, and if not managed properly, it will hinder the subcutaneous immunoglobulin market during the forecast period.
In July 2019, Grifols announced that Xembify has been approved by the US Food and Drug Administration. This is a new 20% subcutaneous immunoglobulin product for the treatment of patients with idiopathic immunodeficiency 2 years and older.
The increase in the incidence of autoimmune diseases will help drive the growth of this market during the forecast period. The deepening of the aging population has led to an increase in the infectivity of the elderly population, and the prevalence of several diseases such as cancer, diabetes and neurological diseases is rising, which has driven the global demand for subcutaneous immunoglobulin market.
This report elaborates on the current development of the Subcutaneous Immunoglobulins industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
CSL
Grifols
Shire (Baxalta)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
10% Purity
20% Purity
Application:
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Subcutaneous Immunoglobulins Industry Overview
-
1.1.1 Subcutaneous Immunoglobulins Market Scope and Market Segments
-
1.1.2 Subcutaneous Immunoglobulins Industry Characteristics
-
1.1.3 Global and China Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Subcutaneous Immunoglobulins Production Value and Growth Rate (2017-2028)
-
1.2 Global Subcutaneous Immunoglobulins Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 10% Purity
-
1.2.2 20% Purity
-
1.3 Global Subcutaneous Immunoglobulins Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Primary Immunodeficiency
-
1.3.2 Secondary Immunodeficiency
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Subcutaneous Immunoglobulins Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Subcutaneous Immunoglobulins Industry Porter's Five Forces Model Analysis
-
2.2.3 Subcutaneous Immunoglobulins Industry PEST Analysis
-
2.3 Subcutaneous Immunoglobulins Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Subcutaneous Immunoglobulins Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Subcutaneous Immunoglobulins Industry
Chapter 3 Global and China Subcutaneous Immunoglobulins Market, by Manufacturer
-
3.1 Global and China Subcutaneous Immunoglobulins Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Subcutaneous Immunoglobulins Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Subcutaneous Immunoglobulins Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Subcutaneous Immunoglobulins Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Subcutaneous Immunoglobulins Market Top 3 Players
Chapter 4 Global and China Subcutaneous Immunoglobulins Market, by Type (2017-2028)
-
4.1 Subcutaneous Immunoglobulins Market Trend, by Type
-
4.2 Global Subcutaneous Immunoglobulins Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Subcutaneous Immunoglobulins Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Subcutaneous Immunoglobulins Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Subcutaneous Immunoglobulins Price Trend, by Type (2017-2028)
-
4.3 China Subcutaneous Immunoglobulins Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Subcutaneous Immunoglobulins Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Subcutaneous Immunoglobulins Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Subcutaneous Immunoglobulins Price Trend, by Type (2017-2028)
Chapter 5 Global and China Subcutaneous Immunoglobulins Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Subcutaneous Immunoglobulins Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Subcutaneous Immunoglobulins Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Subcutaneous Immunoglobulins Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Subcutaneous Immunoglobulins Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Subcutaneous Immunoglobulins Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Subcutaneous Immunoglobulins Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Subcutaneous Immunoglobulins Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Subcutaneous Immunoglobulins Market Analysis
-
7.1 North America Subcutaneous Immunoglobulins Market, by Type
-
7.2 North America Subcutaneous Immunoglobulins Market, by Application
-
7.3 North America Subcutaneous Immunoglobulins Market Analysis and Forecast, by Country
-
7.3.1 United States Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Subcutaneous Immunoglobulins Market Analysis
-
8.1 Europe Subcutaneous Immunoglobulins Market, by Type
-
8.2 Europe Subcutaneous Immunoglobulins Market, by Application
-
8.3 Europe Subcutaneous Immunoglobulins Market Analysis and Forecast, by Country
-
8.3.1 Germany Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Subcutaneous Immunoglobulins Market Analysis
-
9.1 APAC Subcutaneous Immunoglobulins Market, by Type
-
9.2 APAC Subcutaneous Immunoglobulins Market, by Application
-
9.3 APAC Subcutaneous Immunoglobulins Market Analysis and Forecast, by Country
-
9.3.1 China Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Market Analysis
-
10.1 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Market, by Type
-
10.2 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Market, by Application
-
10.3 Latin America, Middle East and Africa Subcutaneous Immunoglobulins Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Subcutaneous Immunoglobulins Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Subcutaneous Immunoglobulins Company Profiles
-
11.1 CSL
-
11.1.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 CSL Subcutaneous Immunoglobulins Product Profiles, Application and Specification
-
11.1.3 CSL Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Grifols
-
11.2.1 Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Grifols Subcutaneous Immunoglobulins Product Profiles, Application and Specification
-
11.2.3 Grifols Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Shire (Baxalta)
-
11.3.1 Shire (Baxalta) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Shire (Baxalta) Subcutaneous Immunoglobulins Product Profiles, Application and Specification
-
11.3.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Subcutaneous Immunoglobulins Industry Investment Prospect and Risk Assessment
-
12.1 Subcutaneous Immunoglobulins Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Subcutaneous Immunoglobulins Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Production Value and Growth Rate (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Production Value and Growth Rate (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Secondary Immunodeficiency (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Subcutaneous Immunoglobulins Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Subcutaneous Immunoglobulins Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Subcutaneous Immunoglobulins Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Subcutaneous Immunoglobulins Market Share, by Manufacturer in 2021
-
Figure Global and China Subcutaneous Immunoglobulins Market Share, by Manufacturer in 2022
-
Table Global Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Value, by Type (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Value Share, by Type (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Price Trend, by Type (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Value, by Type (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Value Share, by Type (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Price Trend, by Type (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Value, by Application (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Sales Value Share, by Application (2017-2028)
-
Figure Global Subcutaneous Immunoglobulins Sales Value Share, by Application (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Value, by Application (2017-2028)
-
Table China Subcutaneous Immunoglobulins Sales Value Share, by Application (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Value Share, by Application (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
Figure North America Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Subcutaneous Immunoglobulins Production, Import, Consumption and Export (2017-2022)
-
Table North America Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table North America Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure North America Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table North America Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table North America Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure North America Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure United States Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure United States Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Canada Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Table Europe Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table Europe Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure Europe Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table Europe Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table Europe Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure Europe Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure Germany Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure UK Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure UK Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure France Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure France Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Italy Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Spain Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Poland Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Russia Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Table APAC Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table APAC Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure APAC Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table APAC Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table APAC Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure APAC Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure China Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Japan Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure India Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure India Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Subcutaneous Immunoglobulins Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Subcutaneous Immunoglobulins Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Subcutaneous Immunoglobulins Sales Value and Growth Rate (2017-2028)
-
Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Product Profiles, Application and Specification
-
Table CSL Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Grifols Product Profiles, Application and Specification
-
Table Grifols Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shire (Baxalta) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shire (Baxalta) Product Profiles, Application and Specification
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
